macro

Sartorius lifts nine-month margin as sales reach 2.74 billion euros

Sartorius kept its 2026 outlook and partly refined it. Nine-month sales reached 2,737 million euros, while the underlying EBITDA margin rose to 30.2%.

the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner. connect the api →

what happened

According to Reuters, Sartorius AG reported nine-month sales of 2,737 million euros for 2026. Its underlying EBITDA margin improved by 0.5 percentage points to 30.2%. Management confirmed its full-year guidance and partly refined it.

Growth in lab products and services is now expected to land near the top of the 4 to 6 percent range, compared with the earlier view of the upper half. Operating cash flow rose 9.9% over the first nine months to 562 million euros.

why it matters

For investors, the mix of higher sales, better margins and stronger cash generation stands out. Narrowing the lab segment forecast toward the upper end signals confidence in demand, which matters for how the laboratory equipment sector is priced.

market impact

Lab equipment sector: solid results and a refined outlook support sentiment around Sartorius shares

tags

instruments

Sartorius AGLab products & servicesMDAX

sources

  1. Sartorius AG 9M Sales Revenue Of EUR 2,737 Mln — Reuters, 22 October 2026 at 05:03 UTC

prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.

the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner.

get stories in real time ↗